Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof

a technology of phosphaplatin and purification method, which is applied in the field of synthetic methods for the preparation of phosphaplatin compounds, can solve problems such as literature limitations, and achieve the effects of reducing time, reducing the limitation on the upper end of concentration, and reducing the tim

Active Publication Date: 2014-09-25
PROMONTORY THERAPEUTICS INC
View PDF11 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This method enables the reproducible production of high-purity monomeric platinum pyrophosphate complexes on a commercial scale, overcoming previous limitations and achieving high yields and quality, suitable for pre-clinical and clinical applications.

Problems solved by technology

Such a limitation is encountered in the literature due to precipitation of pyrophosphoric acid and / or its salts.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof
  • Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof
  • Synthetic and Purification Methods for Phosphaplatin Compounds and Uses Thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of trans-(1R,2R)-DACH-Pt—Cl2

[0101]Potassium tetrachloroplatinate (85.0 gm 0.02 mole) was dissolved in 633 ml of deionized water and filtered. To the resulting red solution was added a solution of trans-(1R,2R)-cyclohexyldiamine (28.0 gm 0.24 mole) dissolved in 126 ml of deionized water. The resulting reaction mixture was stirred for 66 hours at 20° C. during which time a yellow precipitate formed. The suspension was filtered and the solids washed sequentially with deionized water (500 ml) and methanol (402 gm), followed by vacuum drying at 40° C. / 25 mbar, to afford 71.11 gm (91.3%) yield of a yellow solid, trans-(1R,2R)-DACH-Pt—Cl2. HPLC purity; 98.8% area.

example 2

Synthesis of (R,R)-DACH-2 (Repeating Bose Method at an 8× Scale)

[0102]Trans-(1R,2R)-DACH-Pt—Cl2 (0.8 gm, 1.649 mmole) was added to a solution of tetrasodium pyrophosphate decahydrate (3.2 gm, 7.10 mmole) in 1981 ml of deionized water. The solution was adjusted to pH 8 with 2 N nitric acid (approx. 0.08 gm), heated to 40° C. and stirred for 15 hours during which time the pH decreased to about 6.6. The reaction mixture was concentrated to a residual volume of 40 ml by reduced pressure evaporation. The pH of the concentrate was 5.7. The stirred solution, immersed in an ice bath, was adjusted to pH 2 with 2 N nitric acid (approx. 1 gm). A precipitate slowly formed which was isolated by filtration and washed sequentially with cold deionized water (79 ml) and acetone (63 gm). Vacuum drying afforded a greenish solid. The first experiment afforded 0.13 gm (6.3%), while the second afforded 0.30 gm (29.8%) product. The latter sample showed a single 31P NMR resonance at +1.51 ppm (bicarbonate ...

example 3

Portion-wise Addition of DACH-Pt—Cl2

[0103]Tetrasodium pyrophosphate decahydrate (20.5 gm 46 mmole) was dissolved in 250 ml of deionized water. The mixture was adjusted to pH 8 with 2 N nitric acid (3-5 ml). The solution was heated to 40° C. and DACH-Pt—Cl2 (5.0 gm, 13.1 mmole) was added in 5×1 gm portions over an 8 hr period. The resulting suspension was stirred for an additional 15 hr at 40° C. during which time all of the solids did not dissolve. The reaction mixture was increased to 60° C. and stirring was continued for an additional 22 hour during which time all of the solids had dissolved to afford a clear greenish colored solution. The solution was cooled to ambient temperature and the pH adjusted to 2 with 2 N nitric acid (30-35 ml). On further cooling to 5° C. a precipitate formed. The green solid was collected by filtration, and sequentially washed with deionized water (3×15 ml) and methanol (3×15 ml). Vacuum drying afforded 2.6 gm (40.9% yield) of a greenish colored solid...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

This application discloses novel methods and processes for preparation and purification of phosphaplatin compounds. The improvements of the synthetic methods and purification processes include, but are not limited to, efficient and reproducible large-scale preparation of these useful pharmaceutical agents in high quality and good yield.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61 / 651,200, filed on May 24, 2012, which is incorporated herein by reference in its entirety.FIELD OF THE INVENTION[0002]This application relates to synthetic methods for preparation of phosphaplatin compounds, in particular monomeric platinum pyrophosphate compounds, useful as pharmaceutical agents, and processes for recrystallization and purification of these platinum pyrophosphate compounds.BACKGROUND OF THE INVENTION[0003]Platinum complexes, in particular diamine-based platinum complexes such as cisplatin, carboplatin, and oxaliplatin, are an important class of anti-cancer agents, which have been widely used for treating cancers such as ovarian, testicular, small cell lung, and colorectal cancers.[0004]With the increasing cisplatin / carboplatin-resistance of cancers, for example, ovarian cancer, there have been efforts within industry to rep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07F15/00
CPCC07F15/0093A61P35/00
Inventor LUKE, WAYNE D.JOST, STEFFEN
Owner PROMONTORY THERAPEUTICS INC